Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma (original) (raw)

British Journal of Cancer volume 44, pages 502–505 (1981)Cite this article

Abstract

An analysis of survival time of 57 West European patients with hepatocellular carcinoma was carried out to define which of several possible factors (age, sex, cirrhosis and raised serum alpha-foetoprotein (AFP)) influenced survival. Although survival was significantly longer in younger patients (P less than 0.02) and in patients with normal serum AFP (P less than 0.01), multivariate analysis showed that significant variation in survival time is better explained by the single factor, the presence of cirrhosis, than by AFP level. This does not seem to apply for patients with this tumour in Africa and the Far East, and there may be a fundamental difference in the natural history of the tumour between high- and low-incidence areas.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 24 print issues and online access

$259.00 per year

only $10.79 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Authors

  1. P J Johnson
    You can also search for this author inPubMed Google Scholar
  2. W M Melia
    You can also search for this author inPubMed Google Scholar
  3. M K Palmer
    You can also search for this author inPubMed Google Scholar
  4. B Portmann
    You can also search for this author inPubMed Google Scholar
  5. R Williams
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Johnson, P., Melia, W., Palmer, M. et al. Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.Br J Cancer 44, 502–505 (1981). https://doi.org/10.1038/bjc.1981.218

Download citation

This article is cited by